IL249610A0 - Fusion proteins for treatment of cancer - Google Patents

Fusion proteins for treatment of cancer

Info

Publication number
IL249610A0
IL249610A0 IL249610A IL24961016A IL249610A0 IL 249610 A0 IL249610 A0 IL 249610A0 IL 249610 A IL249610 A IL 249610A IL 24961016 A IL24961016 A IL 24961016A IL 249610 A0 IL249610 A0 IL 249610A0
Authority
IL
Israel
Prior art keywords
cancer
treatment
fusion proteins
fusion
proteins
Prior art date
Application number
IL249610A
Other languages
Hebrew (he)
Other versions
IL249610A (en
Inventor
Porgador Angel
Original Assignee
Nat Inst Biotechnology Negev Ltd
Porgador Angel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Biotechnology Negev Ltd, Porgador Angel filed Critical Nat Inst Biotechnology Negev Ltd
Priority to IL249610A priority Critical patent/IL249610A/en
Publication of IL249610A0 publication Critical patent/IL249610A0/en
Priority to PCT/IL2017/051352 priority patent/WO2018109771A1/en
Publication of IL249610A publication Critical patent/IL249610A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
IL249610A 2016-12-15 2016-12-15 Fusion proteins for treatment of cancer IL249610A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL249610A IL249610A (en) 2016-12-15 2016-12-15 Fusion proteins for treatment of cancer
PCT/IL2017/051352 WO2018109771A1 (en) 2016-12-15 2017-12-14 Fusion proteins for treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL249610A IL249610A (en) 2016-12-15 2016-12-15 Fusion proteins for treatment of cancer

Publications (2)

Publication Number Publication Date
IL249610A0 true IL249610A0 (en) 2017-02-28
IL249610A IL249610A (en) 2017-12-31

Family

ID=60942777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249610A IL249610A (en) 2016-12-15 2016-12-15 Fusion proteins for treatment of cancer

Country Status (2)

Country Link
IL (1) IL249610A (en)
WO (1) WO2018109771A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689086A (en) 2016-07-11 2019-04-26 国家生物技术研究所公司 Fusion protein with extended serum half-life
KR102351041B1 (en) * 2018-12-19 2022-01-13 한국화학연구원 Cell penetrating Domain derived from human LRRC24 protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011044374A1 (en) * 2009-10-07 2011-04-14 Indiana University Research And Technology Corporation Capcna peptide therapeutics for cancer

Also Published As

Publication number Publication date
IL249610A (en) 2017-12-31
WO2018109771A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
IL266847B (en) Methods for treatment of cancer comprising tigit-binding agents
HK1254728A1 (en) An nkg2d-ig fusion protein for cancer immunotherapy
IL264674B1 (en) Anti-siglec-7 antibodies for the treatment of cancer
EP3227330C0 (en) Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
ZA201806819B (en) Pharmaceutical combinations for the treatment of cancer
IL259996A (en) Combinations for the treatment of cancer
SI3473263T1 (en) Combined preparations for the treatment of cancer
HK1250662A1 (en) Immunogenic fusion proteins for the treatment of cancer
IL263835A (en) Exosome-guided treatment of cancer
IL267675A (en) Treatment of advanced her2 expressing cancer
EP3177308A4 (en) Use of peptides that block metadherin-snd1 interaction as treatment for cancer
ZA201902689B (en) Therapeutic protein
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
EP3139955A4 (en) Fusion proteins for treating cancer and related methods
IL258340A (en) Quantifying met protein for cancer treatment
IL249610A (en) Fusion proteins for treatment of cancer
ZA201901505B (en) Phenylalanine-free protein for the treatment of pku
IL263564B (en) Peptides for the treatment of osteoarthritis
HK1256714A1 (en) Methods of manufacturing therapeutic proteins
EP3509609A4 (en) Hsp fusion protein with anti-chemorepellant agent for treatment of cancer
GB201622214D0 (en) treatment of cancer
GB201616715D0 (en) Therapeutic protein
GB201604621D0 (en) Treatment of cancer
GB201604293D0 (en) Treatment of cancer
GB201512723D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed